Presentation Information
[Pj-018A-5]Safety and Efficacy of Dimethyl Fumarate in Japanese MS Patients with Specific Backgrounds
Ichiro Nakashima1, Kazumasa Yokoyama2, Ryusuke Sato3, Haruki Makioka3, Aya Tsuchiya3, Yayoi Sato3, Michihiro Kanda3, Takahiko Saida4,5 (1.Tohoku Medical and Pharmaceutical University, Japan, 2.Eastern Static Neuro-Center, Japan, 3.Biogen Japan Co., Ltd., Japan, 4.Kansai Multiple Sclerosis Center, Japan, 5.Kyoto Private Medical Federation Central Hospital, Japan)
1994 Graduated from Tohoku University
1999 Clinical Fellow, Department of Neurology, Tohoku University
2001 Assistant Professor, Department of Neurology, Tohoku University
2007 Visiting Scholar, Montreal Neurological Institute, McGill University
2008 Senior Lecturer & Assistant Professor, Department of Neurology, Tohoku University
2013 Associate Professor, Department of Neurology, Tohoku University
2017 Professor, Division of Neurology, Tohoku Medical and Pharmaceutical University
Currently President of the Japanese Society of Neuroimmunology, Board Certified Member of the Japanese Society of Neurology and the Japanese Society of Internal Medicine, and Councilor of the Japanese Society of Neurology and the Japanese Society of Neurotherapeutics.
1999 Clinical Fellow, Department of Neurology, Tohoku University
2001 Assistant Professor, Department of Neurology, Tohoku University
2007 Visiting Scholar, Montreal Neurological Institute, McGill University
2008 Senior Lecturer & Assistant Professor, Department of Neurology, Tohoku University
2013 Associate Professor, Department of Neurology, Tohoku University
2017 Professor, Division of Neurology, Tohoku Medical and Pharmaceutical University
Currently President of the Japanese Society of Neuroimmunology, Board Certified Member of the Japanese Society of Neurology and the Japanese Society of Internal Medicine, and Councilor of the Japanese Society of Neurology and the Japanese Society of Neurotherapeutics.